Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …

Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Identifying drugs that regulate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) infection and its symptoms has been a pressing area of investigation during the …

Objectives To assess the association between routinely prescribed non-steroidal anti-
inflammatory drugs (NSAIDs) and deaths from COVID-19 using OpenSAFELY, a secure …

SARS-CoV-2 is a novel coronavirus that infects cells through the angiotensin-converting
enzyme 2 receptor, aided by proteases that prime the spike protein of the virus to enhance …

Background Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the
treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …

Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …

With daily increasing of suspected COVID-19 cases, the likelihood of the virus mutation
increases also causing the appearance of virulent variants having a high level of replication …

Abstract Objective Since the World Health Organization (WHO) announced coronavirus
disease 2019 (COVID-19) had become a global pandemic on March 11, 2020, the number …

Early in the COVID-19 pandemic, anecdotal reports emerged suggesting non-steroidal anti-
inflammatory drugs (NSAIDs) may increase susceptibility to infection and adversely impact …